These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 9531734)
1. [Growth hormone deficiency and its treatment in adults]. Weiss V Cas Lek Cesk; 1998 Feb; 137(4):120-3. PubMed ID: 9531734 [TBL] [Abstract][Full Text] [Related]
2. [deficiency of growth hormone in children. Re-evaluation after therapeutic completion]. Martins T; Bastos M; Leitão P; Barros L; Ruas L; Batista C; Paiva S; Carvalheiro M; Ruas MM Acta Med Port; 2000; 13(5-6):283-5. PubMed ID: 11234493 [TBL] [Abstract][Full Text] [Related]
3. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy. Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342 [TBL] [Abstract][Full Text] [Related]
4. [Total body composition in adult patients with growth hormone deficiency before and after its administration]. Weiss V; Krsek M; Marek J; Stĕpán J; Malík J Vnitr Lek; 2003 Aug; 49(8):650-5. PubMed ID: 14518091 [TBL] [Abstract][Full Text] [Related]
5. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency]. Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397 [TBL] [Abstract][Full Text] [Related]
6. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A; Murray RD; Teasdale GM; Shalet SM Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963 [TBL] [Abstract][Full Text] [Related]
7. The advantage of measuring spontaneous growth hormone (GH) secretion compared with the insulin tolerance test in the diagnosis of GH deficiency in young adults. Radetti G; di Iorgi N; Paganini C; Gastaldi R; Napoli F; Lorini R; Maghnie M Clin Endocrinol (Oxf); 2007 Jul; 67(1):78-84. PubMed ID: 17466007 [TBL] [Abstract][Full Text] [Related]
8. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children. Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249 [TBL] [Abstract][Full Text] [Related]
9. Growth hormone secretion in adult patients with thalassaemia. La Rosa C; De Sanctis V; Mangiagli A; Mancuso M; Guardabasso V; Galati MC; Caruso-Nicoletti M Clin Endocrinol (Oxf); 2005 Jun; 62(6):667-71. PubMed ID: 15943827 [TBL] [Abstract][Full Text] [Related]
11. Growth hormone therapy for adult growth hormone deficiency. Shalet SM Int J Clin Pract; 1998 Mar; 52(2):108-11. PubMed ID: 9624793 [TBL] [Abstract][Full Text] [Related]
12. [Growth hormone deficiency in children and adults]. Krysiak R; Okopień B; Herman ZS Pol Merkur Lekarski; 2005 Nov; 19(113):704-9. PubMed ID: 16498817 [TBL] [Abstract][Full Text] [Related]
13. [Still no indications that the treatment of growth hormone deficient adults with growth hormones is unsafe]. Janssen JA; Visser WE; van der Lely AJ Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1486-9. PubMed ID: 15481571 [TBL] [Abstract][Full Text] [Related]
14. [Adult height of patients after long-term treatment of idiopathic growth hormone deficiency. (Czech Registry 1991-1998)]. Zapletalová J; Lebl J; Janstová V; Kalvachová B; Novotná D; Philippiová O Cas Lek Cesk; 2000 Aug; 139(17):529-32. PubMed ID: 11109285 [TBL] [Abstract][Full Text] [Related]
15. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD. Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865 [TBL] [Abstract][Full Text] [Related]
17. Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism? Giavoli C; Porretti S; Ferrante E; Cappiello V; Ronchi CL; Travaglini P; Epaminonda P; Arosio M; Beck-Peccoz P Clin Endocrinol (Oxf); 2003 Dec; 59(6):806-10. PubMed ID: 14974926 [TBL] [Abstract][Full Text] [Related]
18. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults. Yuen KC; Dunger DB Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605 [TBL] [Abstract][Full Text] [Related]
19. Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis. Maison P; Chanson P Circulation; 2003 Nov; 108(21):2648-52. PubMed ID: 14623813 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury. Leal-Cerro A; Flores JM; Rincon M; Murillo F; Pujol M; Garcia-Pesquera F; Dieguez C; Casanueva FF Clin Endocrinol (Oxf); 2005 May; 62(5):525-32. PubMed ID: 15853820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]